RNA Therapies. No Boundaries.
We are a delivery platform-enabled RNA therapeutics company.
Our proprietary GENESYS™ delivery platform excludes ionizable cationic lipids entirely, enhancing therapeutic index.
We use bio-inspired lipopeptides to package, protect and precisely deliver RNA drug payloads to previously inaccessible areas of the body.
Our Mission
At Orion Therapeutics, our mission is to revolutionize medicine and transform patient outcomes by unlocking the full potential of RNA therapeutics. Through our innovative GENESYS™ delivery platform, we advance RNA therapies internally and in partnership to target and treat a wide range of diseases with precision and efficacy.
With an unwavering commitment to innovative research, patient-centricity, and ethical excellence, we strive to address critical healthcare challenges. By fostering strategic collaborations and harnessing the potential of genetic medicines, we aim to create a future where no clinical need goes unmet and every patient gains access to life-changing treatments.
What We Do
The Orion GENESYS™
Platform
Enhanced Delivery
Safe, Natural, Biodegradable
Targeted Delivery
Robust Stability Profile
Scalable & Cost-effective
Legal FTO
Enhanced Delivery
Safe, Natural, Biodegradable
Targeted Delivery
Robust Stability Profile
Scalable & Cost-effective
Legal FTO
The Orion
GENESYS™
At Orion Therapeutics, we develop next-generation RNA medicines using our proprietary, multifunctional Orion GENESYS™ LNP delivery platform, which enables efficient and safe delivery of RNA payloads to target cells anywhere in the body.
In The Press
Partnering
Latest News
First recipient of Tennessee’s $5M startup fund has ‘limitless’ drug potential
“InvestTN” announces seven new investments
Nanotechnology-based Drug Delivery Platforms: 5 Startups to Watch!
Orion Therapeutics Wins Golden Ticket Challenge for Lab Space at Biolabs Tufts Launch Pad
Orion Therapeutics wins LSTCON “Venture Forum”
